Digoxin vs Empagliflozin
Digoxin vs Empagliflozin: Overview
This comparison examines the pharmacological differences between Digoxin and Empagliflozin.
Mechanism of Action
Digoxin: Inhibits Na+/K+-ATPase, increasing intracellular calcium.
Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.
Pharmacokinetics
Half-life: Digoxin β 36-48 hours; Empagliflozin β 12.4 hours.
Chemical Properties
Molecular Formula: Digoxin β C41H64O14; Empagliflozin β C23H27ClO7.
Molecular Weight: Digoxin β 780.9430 g/mol; Empagliflozin β 450.9100 g/mol.
Type: Digoxin β Small molecule; Empagliflozin β Small molecule.